Isolation and quantification of soluble Alzheimer's beta-peptide from biological fluids. - Wikidata - wikimedia - TriplyDB

Isolation and quantification of soluble Alzheimer's beta-peptide from biological fluids.

Isolation and quantification of soluble Alzheimer's beta-peptide from biological fluids.

http://www.wikidata.org/entity/Q34255552

about

Alpha1-antichymotrypsin/Alzheimer's peptide Abeta(1-42) complex perturbs lipid metabolism and activates transcription factors PPARgamma and NFkappaB in human neuroblastoma (Kelly) cells The coexistence of an equal amount of Alzheimer's amyloid-β 40 and 42 forms structurally stable and toxic oligomers through a distinct pathway Association of a novel human FE65-like protein with the cytoplasmic domain of the beta-amyloid precursor protein Molecular cloning of cDNA encoding an unrecognized component of amyloid in Alzheimer disease Lysosomal processing of amyloid precursor protein to A beta peptides: a distinct role for cathepsin S beta-Amyloid-(1-42) is a major component of cerebrovascular amyloid deposits: implications for the pathology of Alzheimer disease A capillary electrophoresis method for evaluation of Abeta proteolysis in vitro Biological markers of amyloid beta-related mechanisms in Alzheimer's disease Curcumin and its derivatives: their application in neuropharmacology and neuroscience in the 21st century Soluble oligomers of the amyloid beta-protein impair synaptic plasticity and behavior Protein aggregation in the brain: the molecular basis for Alzheimer's and Parkinson's diseases Aggregation and disaggregation of senile plaques in Alzheimer disease BACE2, a beta -secretase homolog, cleaves at the beta site and within the amyloid-beta region of the amyloid-beta precursor protein Overview of Alzheimer's Disease and Some Therapeutic Approaches Targeting Aβ by Using Several Synthetic and Herbal Compounds Targeting the proper amyloid-beta neuronal toxins: a path forward for Alzheimer's disease immunotherapeutics Physicochemical properties of cells and their effects on intrinsically disordered proteins (IDPs)The role of APP and BACE1 trafficking in APP processing and amyloid-β generation Dementia of the eye: the role of amyloid beta in retinal degeneration Platelets and Alzheimer's disease: Potential of APP as a biomarker Early etiology of Alzheimer's disease: tipping the balance toward autophagy or endosomal dysfunction?Tailoring the antibody response to aggregated Aß using novel Alzheimer-vaccines Molecular basis for passive immunotherapy of Alzheimer's disease Crystal Structure of the E2 Domain of Amyloid Precursor Protein-like Protein 1 in Complex with Sucrose Octasulfate APP processing in Alzheimer's disease Regulation of beta-amyloid secretion by FE65, an amyloid protein precursor-binding protein Protection against beta-amyloid-induced apoptosis by peptides interacting with beta-amyloid Alzheimer's beta-amyloid peptide specifically interacts with and is degraded by insulin degrading enzyme Trafficking and proteolytic processing of APP Increased beta-amyloid levels in the choroid plexus following lead exposure and the involvement of low-density lipoprotein receptor protein-1 CD36 coordinates NLRP3 inflammasome activation by facilitating intracellular nucleation of soluble ligands into particulate ligands in sterile inflammation Preferential interactions between ApoE-containing lipoproteins and Aβ revealed by a detection method that combines size exclusion chromatography with non-reducing gel-shift Numerical Simulations Reveal Randomness of Cu(II) Induced Aβ Peptide Dimerization under Conditions Present in Glutamatergic Synapses Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins Alzheimer's associated β-amyloid protein inhibits influenza A virus and modulates viral interactions with phagocytes.The sour side of neurodegenerative disorders: the effects of protein glycation.Biophysical insights into how surfaces, including lipid membranes, modulate protein aggregation related to neurodegeneration.Human antibodies reactive with beta-amyloid protein in Alzheimer's disease Stem cell derived basal forebrain cholinergic neurons from Alzheimer's disease patients are more susceptible to cell death.Cholesterol is an important factor affecting the membrane insertion of beta-amyloid peptide (A beta 1-40), which may potentially inhibit the fibril formation.Selection of peptides binding to the amyloid b-protein reveals potential inhibitors of amyloid formation.

P2860

Q24292273-69145FC7-8CA2-4F47-833E-90658FEBBC3A Q24294387-DC8BBFB5-31AF-4C83-8D98-4A78EF3E0FFF Q24312931-27CA86BD-B6B1-4900-AFF4-F9B92198C980 Q24321355-0C55FC86-EBC4-4F44-A578-AB150DEA5AA7 Q24528220-67A2DD93-1B0E-4CA5-812A-89F60CACBADE Q24564120-6C4B9417-80DB-42C1-924F-B487B44B0A4F Q24620093-BFB08804-A993-4D3C-917C-436C20A8A424 Q24622136-37A6C481-BC82-4842-AC77-7CB9616C7738 Q24630927-245648DC-3D8B-40FC-BC42-C92937BED383 Q24645994-FD9A6C06-C58E-4230-8502-23D15B952128 Q24650014-B91D177F-6A55-4340-A4A6-4B7D312E33EE Q24653813-E49FFE2E-1608-4A38-8C9A-F5302A41EF54 Q24675964-8B22B9A5-9B25-4986-B280-17C881152BC1 Q26749061-93227D79-E038-405E-8A81-F2B50B07D753 Q26822002-2074221B-4D71-4A7E-A75A-8E04DB725F60 Q26823798-A60491FE-1042-42AD-BD86-C1B3B29F345C Q26825686-B63B93B2-8E74-4DB2-A952-80282FB67910 Q26828978-6FAFB353-DA00-4E1E-AE25-389F1B1F65C7 Q27001550-4CD45007-0A58-484A-ABE2-14D1DDFC13D2 Q27026907-0EA9BCAC-51D7-43B8-80EC-63BE15E4AB7F Q27320084-97E30CAE-CAF9-4AEC-9C9B-9E03701D3673 Q27648521-211484F2-C128-4BF4-8F4A-70443B763F04 Q27670602-2A6610C6-DAD9-4CDF-BF7D-491BD9AB0673 Q27694738-9C50119E-ACEB-4692-88EC-6F597045179E Q28138703-23228EA6-69F5-4909-8F30-4F42A6B2B1DF Q28244030-1A933FB0-964D-4A08-9D1D-57DD8E44064A Q28254283-B70CCB5C-1AD5-49BF-9F38-015B08E3D566 Q28265871-5BA89A46-B50A-451D-84D6-6EA742FC9362 Q28391263-E1488236-FBE4-455B-AC25-B42DAB776ECC Q28506984-E5924D35-9976-48D3-84B9-04C468DCAC7F Q28582464-6EAE63A5-CFDF-4901-A85C-61B312AD2AA4 Q28818161-9CEAE894-9231-4B75-8ACD-05AE75C4BF8E Q29547593-A7B8E3BB-71E8-4E8D-A053-8AD4775FE6E5 Q30364254-64672475-3197-464A-8070-EE6ED5F4286A Q30386079-AD5CFDF1-0623-4037-A3F4-E7EDDC0ADC0B Q30427825-0AE45328-F8C8-470B-9120-5E3CE702BCAF Q30442882-BC7FFA52-8927-43A6-BB18-D970713C6197 Q30566020-AC33CD52-1B09-48C9-9AD0-135ECC63556A Q30777774-59CA0384-1A48-4FF1-A47D-EDA6B0AB7051 Q30805913-E9E808D5-3956-4AB3-ABCE-DD60DEA33068

P2860

Isolation and quantification of soluble Alzheimer's beta-peptide from biological fluids.

http://www.wikidata.org/entity/Q34255552

description

1992 nî lūn-bûn

@nan

1992 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

1992 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

1992年の論文

@ja

1992年論文

@yue

1992年論文

@zh-hant

1992年論文

@zh-hk

1992年論文

@zh-mo

1992年論文

@zh-tw

1992年论文

@wuu

name

Isolation and quantification of soluble Alzheimer's beta-peptide from biological fluids.

@ast

Isolation and quantification of soluble Alzheimer's beta-peptide from biological fluids.

@en

Isolation and quantification of soluble Alzheimer's beta-peptide from biological fluids.

@nl

type

label

Isolation and quantification of soluble Alzheimer's beta-peptide from biological fluids.

@ast

Isolation and quantification of soluble Alzheimer's beta-peptide from biological fluids.

@en

Isolation and quantification of soluble Alzheimer's beta-peptide from biological fluids.

@nl

prefLabel

Isolation and quantification of soluble Alzheimer's beta-peptide from biological fluids.

@ast

Isolation and quantification of soluble Alzheimer's beta-peptide from biological fluids.

@en

Isolation and quantification of soluble Alzheimer's beta-peptide from biological fluids.

@nl

P1433

Q34255552-E47C1F7E-1189-4554-BC9F-D50F5D91A7ED

P1476

Q34255552-792DAE91-06D4-43C2-99E5-B969180A2D95

P2093

Q34255552-004610EB-658A-41D6-B974-762388336C43

Q34255552-4BB05B3E-3A36-467A-A5C9-A4CC52708E4F

Q34255552-4F8E43F3-F84A-4595-BC46-8BDBF34FB8A5

Q34255552-642FA86D-19FC-4CB2-BB79-258D752B4AFD

Q34255552-6681E1D5-D0ED-4F89-BD4C-10565B98C27C

Q34255552-66F75A1E-5F3B-450E-A68F-D2C723CA6583

Q34255552-6F6D5DF0-DD41-4084-BC88-3CF774EED7BC

Q34255552-8332A201-3748-43A5-B77F-CBE21A7CB337

Q34255552-DF90F39E-D02A-434F-BAB3-2812679C85D9

Q34255552-EB988D5F-1363-4E97-AC00-F98A974C2466

P2888

Q34255552-A1B36722-1CB2-48BA-89DD-5C9388AAF56B

P304

Q34255552-F56A2763-F0EA-4A93-96DB-8EDC0354DD6A

P31

Q34255552-50A24251-BB49-41D6-A417-F08E7236C8DB

P356

Q34255552-09E51D7E-425D-4C02-A36E-D78D2D20D8FB

P407

Q34255552-59756EA9-ECEA-4AD2-ABA4-383C927CBDE4

P433

Q34255552-F41A4247-C035-4CBC-8BB9-80D89FBD782E

P478

Q34255552-0A5538DE-D39C-452F-A848-45C1504A7352

P577

Q34255552-41CEE1E7-83DE-4902-B13B-3F224FDE353B

P6179

Q34255552-220EDBF9-B6A8-4A3F-B4F8-141CF0962D36

P698

Q34255552-FE0E2470-D713-4E94-BA90-712ADEC1A6C9

P921

Q34255552-9763BBFB-2A6C-4801-BF2C-11E0840F0BF9

P356

P1433

P1476

Isolation and quantification of soluble Alzheimer's beta-peptide from biological fluids.

@en

P2093

Davis D

http://www.w3.org/2001/XMLSchema#string

Dovey H

http://www.w3.org/2001/XMLSchema#string

Esch F

http://www.w3.org/2001/XMLSchema#string

Lee M

http://www.w3.org/2001/XMLSchema#string

Schlossmacher M

http://www.w3.org/2001/XMLSchema#string

Seubert P

http://www.w3.org/2001/XMLSchema#string

Sinha S

http://www.w3.org/2001/XMLSchema#string

Swindlehurst C

http://www.w3.org/2001/XMLSchema#string

Vigo-Pelfrey C

http://www.w3.org/2001/XMLSchema#string

Whaley J

http://www.w3.org/2001/XMLSchema#string

P2888

P304

325-327

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/359325A0

http://www.w3.org/2001/XMLSchema#string

P407

P433

6393

http://www.w3.org/2001/XMLSchema#string

P478

359

http://www.w3.org/2001/XMLSchema#string

P577

1992-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1020938642

http://www.w3.org/2001/XMLSchema#string

P698

1406936

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease